Network News

YUMAB and MOLCURE Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets

YUMAB and MOLCURE Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets

RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU

RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category

Helmholtz High Impact Award 2024 presented

Helmholtz High Impact Award 2024 presented

New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute

New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute

Otto Meyerhof Medal for Hendrik Dietz

Otto Meyerhof Medal for Hendrik Dietz

ERC funding for new approach against malaria

ERC funding for new approach against malaria

ERC Starting Grant for DKFZ researcher Jens Puschhof

ERC Starting Grant for DKFZ researcher Jens Puschhof